Bosh sahifaCHGCF • OTCMKTS
add
Chugai Pharmaceutical Co Ltd
Yopilish kursi
48,01 $
Kunlik diapazon
55,23 $ - 60,00 $
Yillik diapazon
29,75 $ - 72,30 $
Bozor kapitalizatsiyasi
13,89 trln JPY
Oʻrtacha hajm
3,75 ming
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
TYO
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (JPY) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 288,46 mlrd | 21,74% |
Joriy xarajat | 63,99 mlrd | -0,22% |
Sof foyda | 97,23 mlrd | 30,69% |
Sof foyda marjasi | 33,71 | 7,36% |
Har bir ulushga tushum | — | — |
EBITDA | 137,05 mlrd | 36,68% |
Amaldagi soliq stavkasi | 28,41% | — |
Balans
Jami aktivlari
Jami passivlari
| (JPY) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 944,55 mlrd | 23,54% |
Jami aktivlari | 2,14 trln | 12,74% |
Jami passivlari | 232,26 mlrd | -9,17% |
Umumiy kapital | 1,91 trln | — |
Tarqatilgan aksiyalar | 1,65 mlrd | — |
Narxi/balansdagi bahosi | 0,04 | — |
Aktivlardan daromad | 15,71% | — |
Kapitaldan daromad | 17,94% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (JPY) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 97,23 mlrd | 30,69% |
Operatsiyalardan naqd pul | 66,68 mlrd | -33,93% |
Sarmoyadan naqd pul | -86,89 mlrd | -169,46% |
Moliyadan naqd pul | -95,38 mlrd | -42,63% |
Naqd pulning sof oʻzgarishi | -116,78 mlrd | -2 887,85% |
Boʻsh pul | 19,18 mlrd | -75,37% |
Haqida
Chugai Pharmaceutical Co., Ltd. is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO. Wikipedia
CEO
Tashkil etilgan
10-mar, 1925
Xodimlar soni
5 026
